Drug Information

General Information
Drug ID
DR00608
Drug Name
Loracarbef
Synonyms
(6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7S)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; (6R,7S)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7S)-7-{[(2R)-2-ammonio-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; 7beta-[(2R)-2-amino-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylate; 7beta-[(2R)-2-amino-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylic acid; 7beta-[(2R)-2-ammonio-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylate; KT-3777; LY-163892; Lorabid; Lorabid (TN); Loracarbef hydrate; Loracarbefum; Lorafem
Drug Type
Small molecular drug
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C16H16ClN3O4
Canonical SMILES
C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
InChI
InChI=1S/C16H16ClN3O4/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24)/t10-,11-,12+/m1/s1
InChIKey
JAPHQRWPEGVNBT-UTUOFQBUSA-N
CAS Number
CAS 76470-66-1
Pharmaceutical Properties Molecular Weight 349.77 Topological Polar Surface Area 113
Heavy Atom Count 24 Rotatable Bond Count 4
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 5
XLogP
-1.7
PubChem CID
5284585
PubChem SID
103269711 ,11039360 ,113863239 ,124766031 ,135743192 ,137185121 ,142043529 ,14876172 ,14952830 ,152035355 ,162654773 ,164811815 ,175266433 ,175611932 ,177749353 ,179116760 ,224046000 ,226420669 ,39317893 ,46506369 ,79621201 ,7979792 ,92741039 ,93166911 ,99450941
TTD Drug ID
D0E9WL

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.